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Abstract
Atrial Fibrillation (AF), the most common sustained arrhythmia, has a strong genetic component, but the mechanism by
which common genetic variants lead to increased AF susceptibility is unknown. Genome-wide association studies (GWAS)
have identified that the single nucleotide polymorphisms (SNPs) most strongly associated with AF are located on
chromosome 4q25 in an intergenic region distal to the PITX2 gene. Our objective was to determine whether the AF-
associated SNPs on chromosome 4q25 were associated with PITX2c expression in adult human left atrial appendages.
Analysis of a lone AF GWAS identified four independent AF risk SNPs at chromosome 4q25. Human adult left atrial
appendage tissue was obtained from 239 subjects of European Ancestry and used for SNP analysis of genomic DNA and
determination of PITX2c RNA expression levels by quantitative PCR. Subjects were divided into three groups based on their
history of AF and pre-operative rhythm. AF rhythm subjects had higher PITX2c expression than those with history of AF but
in sinus rhythm. PITX2c expression was not associated with the AF risk SNPs in human adult left atrial appendages in all
subjects combined or in each of the three subgroups. However, we identified seven SNPs modestly associated with PITX2c
expression located in the introns of the ENPEP gene, ,54 kb proximal to PITX2. PITX2c expression in human adult left atrial
appendages is not associated with the chromosome 4q25 AF risk SNPs; thus, the mechanism by which these SNPs are
associated with AF remains enigmatic.
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Introduction
Atrial Fibrillation (AF), a complex cardiac arrhythmia, is the
most common sustained arrhythmia encountered in clinical
practice and affects over 2.3 million Americans and millions more
worldwide [1]. AF is associated with a 2-fold increase in mortality
and 4- to 5-fold increased risk for stroke, resulting in significant
cost to the healthcare system [1,2]. Previous genome wide
association studies (GWAS) have found that the strongest single
nucleotide polymorphisms (SNPs) associated with AF are located
on chromosome 4q25, with the AF odds ratio for the minor allele
ranging from ,1.4 to 2.0 [3–5]. Among the AF-associated SNPs
on chromosome 4q25, several independent risk variants have been
identified [6]. These SNPs are located in an intergenic region of
chromosome 4q25 with the closest gene, PITX2, located ,171 kb
proximal to the most significant SNP identified in the earliest
GWAS, rs2200733 [5].
PITX2, a member of the bicoid class of homeobox genes, is
expressed in many organs throughout the body, including the
heart and brain [7]. There are 3 major human isoforms, PITX2a,
PITX2b, and PITX2c. PITX2c is the only isoform expressed in the
left atrium [8], and it has been shown to play a critical role in left/
right asymmetry during development in the heart [9]. Using
RNAseq, we have previously shown that PITX2c is expressed in
the human left atrial appendage and not in the right atrial
appendage [8]. Although homozygous Pitx2c deficiency in mice
results in embryonic lethality [10,11], hemizygous Pitx2c +/2 mice
are viable and susceptible to pacing-induced atrial arrhythmia,
making it an attractive candidate as an AF-causal gene [12].
Many SNPs identified in GWAS for complex traits such as
anthropomorphic measures and common diseases are located in
intergenic regions and thus it is challenging to determine the
mechanism for the observed associations. The overriding hypoth-
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esis is that these SNPs affect complex traits by regulating the
expression of nearby genes, thus these SNPs may be classified as
cis-acting expression quantitative trait loci (eQTLs). It is also
challenging to determine which are the causal SNPs, as the index
SNPs may not be causal but in linkage disequilibrium (LD) with
causal SNPs. Recent findings from the ENCODE project show
that most of the GWAS SNPs, or SNPs in strong LD with the
GWAS SNPs, are within regulatory regions. These regions were
identified due to their location within a DNAseI hypersensitive
region or within a site in which histone modification or
transcription factor binding indicates regulatory activity, as
determined by chromatin-immunoprecipitation and next genera-
tion sequencing [13]. We hypothesized that the four SNPs
independently associated with AF in the chromosome 4q25 region
would be associated with PITX2c expression. To study this, we
used SNP arrays to obtain genotypes and quantitative RT-PCR
(qRT-PCR) to measure PITX2c expression in left atrial append-
ages obtained from 239 subjects of European ancestry, including
40 samples from subjects with no history of AF. We found that
these AF-associated SNPs were not associated with PITX2c mRNA
expression in adult left atrial appendages in all subjects combined,
or in the subgroup of subjects with no history of AF. However, we
identified several SNPs in introns of the ENPEP gene, on the
opposite side of the PITX2 gene relative to the location of the AF-
associated SNPs, which were modestly associated with PITX2c
mRNA expression levels. Thus, the mechanism of the AF-
associated SNPS on 4q25 remains unknown.
Materials and Methods
Ethics Statement
All patients provided informed consent for use of discarded
atrial tissue. Prior to 2008 verbal consent was obtained and
documented in the medical records in a process approved by the
Cleveland Clinic Institutional Review Board (IRB). From 2008
onward and for donor tissues, patients provided separate IRB-
approved written informed consent. The IRB approved the studies
included in this report. Subjects were not consented for genetic
information sharing, thus the SNP data cannot be loaded to
dbGAP.
Genome Wide Association Studies (GWAS) and
Identification of Independent AF Associated SNPs at
Chromosome 4q25
Descriptions of the cohorts used in the Cleveland Clinic lone AF
(LAF) GWAS, genotyping, and quality control and filtering of
samples and SNPs were previously described. [3]. Here we include
an additional 111 Caucasian LAF cases from the Cleveland Clinic
Lone Atrial Genebank, all typed on the Illumina Hap610 chip,
giving a total of 607 LAF cases and 2956 population controls for
GWAS and fine mapping analysis. Maximum likelihood logistic
regression was used to estimate the association between odds of
LAF and each of the 479,618 filtered genotyped SNPs. SNPs were
coded as allele dosages. The logistic model included sex and four
principal components of genetic sharing, all of which were
associated with LAF. LAF-SNP association p-values were adjusted
for any residual population stratification using the genomic control
method [14]. Odds ratios of LAF were estimated for each SNP.
Results from our LAF GWAS were used to find independent
LAF-SNP associations in the 4q25 region. Starting with SNP
rs2200733, which was previously reported as the strongest AF-
associated SNP in a GWAS [5] and had the largest odds ratio in
Table 1. PITX2c TaqMan primer and probe set.
Identifier Sequence
PITX2c Forward Primer 59-GCG GTT CCT CTG GAA AGT GG-39
PITX2c Reverse Primer 59-GCA CAC CAT CTC CGA CAC CT-39
Probe* 59/56-FAM/CCC GGA GGC/ZEN/CGC AGA GAA AGA TAA/3IABkFQ/239
*FAM fluorophore with internal ZEN and 39 IOWA BLACK FQ quencher modification.
doi:10.1371/journal.pone.0086245.t001
Figure 1. Adjusted and unadjusted expression of PITX2c in
human left atrial appendages in AF controls. Log2 PITX2c
expression, normalized to ACTC1, in the 16 donor and 24 surgical No
AF samples uncorrected (A), or after correction for age and sex (B).
There was no significant difference in PITX2c expression between these
groups by non-parametric Mann-Whitney t-test. Individual values are
shown along with median and interquartile range.
doi:10.1371/journal.pone.0086245.g001
PITX2c Expression in Human Left Atrial Appendages
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our LAF GWAS, we searched for additional SNPs in the vicinity
of rs2200733 (150 SNPs over 1 Mb) that were independently
associated with LAF using a forward step-wise approach. SNPs
were added until the conditional p-value, adjusting for all SNPs
chosen in the step-wise search, was less than 0.01 with Bonferroni
correction for 150 SNPs (p,6.6761025).
Human Left Atrial Tissue Processing
Human left atrial appendage tissues obtained from elective
surgery were snap frozen in liquid nitrogen and stored at 280uC
until RNA extraction. AF history, type of AF, structural heart
disease, demographics, and other clinical data were collected in a
research database and a prospectively collected database of all
cardiac surgeries (The Cardiovascular Information Registry)
maintained by the Department of Cardiothoracic Surgery.
Subjects were categorized as ‘‘lone AF’’ if they had a history of
AF and did not have coronary artery disease or valvular disease.
AF rhythm status was determined by review of electrocardiograms
obtained prior to surgery. 16 left atrial tissue specimens were
obtained from non-failing donor hearts not used for transplant.
These hearts were perfused with cardioplegia prior to explant and
processed in the same manner as hearts used for organ transplant.
As with the surgical specimens, donor tissue samples were snap
frozen in liquid nitrogen and kept at 280uC until RNA extraction.
Genomic DNA Isolation and SNP Microarray
25–50 mg of left atrial appendage tissue was used to extract
DNA. The tissue, in one mL of DNAzolH (Invitrogen,), was
homogenized (PowerGen700, Fisher Scientific) with sterile Omni
Tip Disposable Generator Probes (Omni International,). DNA was
isolated from the homogenate following the manufacturer’s
protocol. The DNA pellet was resuspended in 20 ml of 10 mM
Tris buffer (pH 7.4) and the DNA concentration was measure with
a NanoDrop ND-1000 Spectrophotometer (Thermo Fisher
Scientific Inc.), diluted to 100 ng/ml and stored at 220oC until
use. The DNA was genotyped using Illumina Hap550v3 and
Hap610-quad SNP microarrays. Only directly genotyped SNPs
were used in this study.
RNA Isolation
50–100 mg of left atrial appendage tissue was used to extract
RNA. The tissue, in one ml of TRIzolH (Invitrogen), was
homogenized with a sterile Omni Tip Disposable Generator
Table 2. Left atrial appendage surgical and donor patient characteristics.
Patient Characteristics Total N = 239
No AF n = 40 (16
donors),17% AF/SR n = 78, 33% AF/AF n = 121, 50% P-Value
Sex, Female, % 23% 35% 24% 19% 0.11#
Age (years)* 61 (53, 69) 62 (51,71) 59 (52, 65) 64 (55, 70) 0.040
$
BMI (kg/m2)*& 27.8 (24.7, 31.6) 26.5 (23.4,28.3) 27.0 (24.0, 31.4) 28.2 (25.2, 32.2) 0.064
$
Hypertension, %& 51% 60% 41% 56% 0.085#
CAD, %& 34% 50% 29% 34% 0.17#
MVD, %& 49% 70% 53% 43% 0.076#
Lone AF, % 15% 0% 17% 18% 0.78##
*Median (interquartile range).
&Not including donors, for which this information not available.
#p-value by chi-square test.
$
p-value by Kruskal Wallis nonparametric ANOVA.
##p-value by chi-square comparing only AF/SR and AF/AF groups.
doi:10.1371/journal.pone.0086245.t002
Figure 2. Identification of four SNPs independently associated
with AF at the 4q25 locus in the Cleveland Clinic Lone AF
GWAS. A. AF associations of all genotyped SNPs in the 4q25 locus
using the marginal model described in Table 3. The locations of the
PITX2c and ENPEP genes are shown above. The dashed line is the
Bonferroni corrected level of significance for the 150 SNPs tested at
p = 0.01. B. Since many of the SNPs in this region are in LD with each
other, the AF associations were recalculated after adjustment for the
remaining significant SNPs using the full model described in Table 3.
The four independently associated SNPs are in the center of the circles
in both panels.
doi:10.1371/journal.pone.0086245.g002
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Probes. RNA was isolated from the homogenate following the
manufacturer’s protocol. The RNA pellet was dried and
resuspended in 80 ml of DEPC water and the concentration was
measured with the NanoDrop ND-1000 Spectrophotometer and
stored at 280oC.
cDNA Preparation
1 mg of purified RNA was added to 4 ml of SuperscriptH ViloTM
mastermix (Invitrogen) and water added to bring the reaction
volume to 20 ml. The reaction was run in an ABI themocycler at
25uC for 10 min, 42uC for 120 min and 85uC for 5 min with a
4uC hold temp. After completion, 5 ml of the newly synthesized
cDNA was diluted with 90 ml of nuclease free water and stored at
220oC until further use.
Quantitative Reverse Transcriptase-polymerase Chain
Reaction (qRT-PCR)
An Eppendorf Epmotion 5070 robotic pipettor was used to
prepare the working and reaction plates. To prepare the master
mix for each sample, 12.5 ml of the TaqManH gene expression
master mix (Applied Biosystems) was used along with 1.25 ml of
the custom designed PITX2c primer/probe set (Table 1, obtained
from IDT) or SHOX2 primer/probe set (assay number
Hs00243203_m1 from Applied Biosystems) and the primer limited
cardiac actin (ACTC1) primer/probe mix (assay number
Hs00606316_m1 from Applied Biosystems). PITX2c expression
was also normalized to primer limited cyclophilin A (PPIA)
primer/probe mix (assay number Hs04194521_s1 from Applied
Biosystems). This 15 ml mix was pipetted into individual wells of a
96-well working plate. Using the robot, 10 ml of the diluted cDNA
was added. 5 ml of the total mixture from the working plate was
pipetted in triplicate to a 384-well assay plate. PCR was performed
in a Bio-RAD CRX qRT-PCR machine that had been calibrated
for our FAM and VIC fluorescent probes. Thermal cycling was
Table 3. 4q25 SNPs Independently Associated with AF.
Marginal Model Results Full Model Results
SNP Position on Chr 4 MAF OR P-Value OR P-Value
rs2200733 111929618 0.17 2.47 1.80E-25 2.46 1.80E-23
rs10033464 111940210 0.10 1.32 8.34E-03 1.99 2.26E-09
rs3853445 111980936 0.25 0.59 1.14E-09 0.59 3.65E-09
rs1448818 111789672 0.25 1.42 3.87E-06 1.44 7.66E-06
Results from logistic regression fits of the following 2 models.
Marginal Model for each SNP: History of lone AF using as covariates Sex +4 principal components of genetic sharing.
Full Model for each SNP: History of lone AF using as covariates Sex +4 principal components of genetic sharing+other 3 SNPs shown on table.
doi:10.1371/journal.pone.0086245.t003
Table 4. Linkage disequilibrium (r2) of 4 risk/independently
associated AF SNPs in 4q25 Region.
rs2200733 rs3853445 rs1448818 rs10033464
rs2200733 1
rs3853445 0.0018 1
rs1448818 0.047 0.016 1
rs10033464 0.0064 0.110 0.018 1
doi:10.1371/journal.pone.0086245.t004
Figure 3. PITX2 expression was associated with AF history and
rhythm status. A. Unadjusted levels of PITX2c in the different AF
history/rhythm groups revealed a U-shaped relationship with increased
AF-status. PITX2c median levels were 17% higher (antilog2 transformed)
in the AF/AF vs. AF/SR groups (p,0.001). B. PITX2c levels adjusted for
sex and age. The U-shaped relationship was maintained with PITX2c
median levels 24% higher (antilog2 transformed) in the AF/AF vs. AF/SR
groups (p,0.001). Individual subject data is shown along with the
median and interquartile range.
doi:10.1371/journal.pone.0086245.g003
PITX2c Expression in Human Left Atrial Appendages
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performed with a hot-start at 95uC for 10 minutes, followed by 40
cycles of 95uC for 15 seconds and 60uC for 60 seconds. Delta C(t)
values for PITX2c and SHOX2 expression levels were calculated
relative to ACTC1 expression, and the DDCT method was used to
compare expression among samples [15], yielding log2 based
expression values.
PITX2c Expression Analysis
Relative log2 gene expression levels were corrected for plate and
batch effects using three standardized atrial RNA samples on each
plate. Relative expression levels were fit to an additive linear
model including age, gender, donor/surgical sample, atrial
fibrillation history and pre-operative rhythm status, using the R
statistical program. Differences in PITX2c expression among the
rhythm groups was determined by non-parametric ANOVA.
PITX2 eQTL Analysis
For the four AF susceptibility SNPs on chromosome 4q25, relative
PITX2cexpression levelswere fit toanadditive linearmodel including
age, gender, donor/surgical sample, AF history, pre-operative
rhythm status, and genotype using the R statistical program. Analysis
was performed on all 239 samples. For regional eQTL analysis in the
chromosome 4q25 locus, 169 assayed SNPs from the Illumina SNP
microarray +/2500 Kb from the PITX2 gene were tested for
association with PITX2c expression levels using R. This analysis was
confined to 223 samples, excluding the 16 donors, where all clinical
information was known. Relative PITX2c expression levels were fit to
an additive linear model including age, gender, history of coronary
artery disease (CAD),historyofmitral valvedisease (MVD),historyof
hypertension, body mass index (BMI), atrial fibrillation history, pre-
operative rhythm status, and genotype using the R statistical
program. Significance for the regional eQTL p-values was
determined by deviation from the expected values using a quantile-
quantile (QQ) plot. Additional analysis and plotting were performed
with GraphPad Prism software. Power analyses for eQTL studies
wereperformedinRusinga linearmodel testat f2valuesof0.02,0.15,
and 0.35.
Results
Patient Characteristics of 239 Adult Left Atria Tissue
223 left atrial appendages were obtained during cardiac surgery
from subjects of European ancestry. 16 additional were obtained
Table 5. Multivariate Model for PITX2c expression.
Covariate Unadjusted p-value Adjusted p-value# b for adjusted p-value
Sex 0.20 0.22 0.10
Age 1.13E-03 5.79E-03 0.01
BMI& 0.18 0.79 1.57E-03
Hypertension& 0.01 0.24 0.08
CAD& 0.07 0.82 0.02
MVD& 0.03 0.16 20.10
No history of AF/donors 0.25* 0.19
$ 20.15
Donors only 0.185* 0.94
$ 20.013
AF/SR 9.14E-04* 4.59E-03 20.21
*vs. AF/AF group.
#adjusted for all covariates vs. AF/AF group, unless marked otherwise.
&Not including donors, for which this information not available.
$
adjusted only for age and sex vs. AF/AF group.
doi:10.1371/journal.pone.0086245.t005
Figure 4. QQ plot of PITX2c eQTLs in the 4q25 region. Seven
SNPs were far above the expected p-value range for association with
adjusted PITX2c levels.
doi:10.1371/journal.pone.0086245.g004
Figure 5. PITX2c eQTLs for SNPs in the 4q25 region. All
genotyped SNPs +/2500 kb from PITX2c were evaluated for PITX2c
eQTLs. The four AF associated SNPs are shown with arrows. Seven SNPs
within introns of the ENPEP gene were associated with expression of
PITX2c (p,0.01).
doi:10.1371/journal.pone.0086245.g005
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from transplant donors that were not used for transplantation.
Samples were divided into three groups based on their history of
AF and their preoperative rhythm status: no history of AF (No AF,
N = 40); history of AF in sinus rhythm at time of sample collection
(AF/SR, N = 78); and history of AF in AF rhythm at time of
sample collection (AF/AF, N = 121). 24 of the 40 No AF subjects
were in surgery to treat other cardiac conditions, while the
remaining 16 donor samples were assumed to have no history of
AF. There was no significant difference in PITX2c expression
between the 24 No AF surgical samples and the 16 No AF donor
samples before or after correction for sex and age (Figure 1).
However, there was a trend for lower PITX2c expression in the
donor samples. Thus, in subsequent analyses we combined these
40 subjects into one No AF group, and corrected expression for
donor status. We examined if the AF/rhythm status groups were
associated with sex, age, BMI, and history of hypertension, CAD,
and MVD; although, for the No AF group we had to exclude the
donor samples for association with BMI, hypertension, CAD, and
MVD, since this data was not available for these samples (Table 2).
Females constituted 23% of the cohort with no statistically
significant differences in sex among the rhythm groups
(p = 0.11). Age (range 16–86 years old) was associated with
rhythm status with the AF/AF group being the oldest and the AF/
SR group being the youngest (p-value = 0.040). The four subjects
,31 years old were all in the No AF group. BMI for our cohort
ranged from 17.8–46.9, with a trend for the highest BMI in the
AF/AF group and the lowest in the No AF group (p-value
= 0.064). History of hypertension was present in 51% of the
subjects, with a trend towards a higher frequency in the No AF
group (p = 0.085). History of CAD was present in 34% of the
subjects and trended higher in those with No AF (50%, p = 0.17).
History of MVD was present in 49% of the subjects and trended
higher in the No AF group (70%, p = 0.076). Among the 199
subjects with a history of AF, 35 had lone AF. These subjects were
equally represented in the AF/SR and AF/AF groups. However,
the lone AF subjects were significantly younger with a median age
of 56 (45–61 interquartile range) than the other AF subjects with a
median age of 63 (interquartile range 44–70, p,0.0001 by Mann
Whitney two tailed t-test).
Four Independent SNPs at Chromosome 4q25 Associated
with AF
Prior GWAS and meta-analyses have shown that the 4q25 locus
has the strongest association with AF. We performed a GWAS
using 607 Cleveland Clinic lone AF cases and 2956 Illumina
population controls, which confirmed that the strongest locus
associated with AF resides at chromosome 4q25. Figure 2A shows
the fine map of this AF association at 4q25. We performed a
conditional analysis to identify independent SNPs associated with
AF in this region. Four SNPs were found to be independently
associated with AF at the locus-wide significance threshold of
p,6.6761025 (Figure 2B and Table 3). Two of these SNPs,
rs2200733 and rs3853445, had previously been found to be
independently associated with AF [6]. The minor alleles of three of
these SNPs are associated with increased risk, while the minor
allele of rs385445 was associated with decreased risk for AF. The
most highly AF-associated SNP, rs2200733, had an odds ratio of
2.47. These four SNPs are in weak linkage disequilibrium with
each other (Table 4), showing that four separate haplotype blocks
in this locus are associated with AF.
Covariates Affecting PITX2c Expression Levels
Expression of PITX2c normalized to ACTC1 was measured by
qRT-PCR in RNA derived from the left atrial appendages. Log2
PITX2c expression levels were examined in the different AF
history/rhythm groups (Figure 3). Surprisingly, there was a U-
shaped relationship with increased AF disease status, such that
PITX2c expression was higher in subjects with no history of AF,
lower in AF/SR subjects, and higher again in AF/AF subjects,
with this difference highly significant (p = 261024 by non-
parametric Kruskal-Wallis ANOVA) (Figure 3A). Dunn’s AN-
OVA post-test indicated that the only significant difference among








rs2200733 111929618 0.90 0.0084 [20.12–0.14] 0.72
rs3853445 111980936 0.68 0.027 [20.10*0.15] 0.96
rs1448818 111789672 0.40 0.0548 [20.073–0.18] 0.37
rs10033464 111940210 0.15 2.0936 [20.23–0.034] 0.09
*corrected for sex, age, donor status, and AF history/rhythm.
CI, confidence interval.
doi:10.1371/journal.pone.0086245.t006
Table 7. Chr. 4 AF risk SNPs not associated with PITX2c normalized to PPIA expression.
SNP location PITx2c p-value uncorrected PITX2c p-value phenotype corrected*
rs2200733 111929618 0.25 0.39
rs3853445 111980936 0.63 0.97
rs1448818 111789672 0.40 0.33
rs10033464 111940210 0.81 0.51
*corrected for sex, age, donor status, and AF history/rhythm.
doi:10.1371/journal.pone.0086245.t007
PITX2c Expression in Human Left Atrial Appendages
PLOS ONE | www.plosone.org 6 January 2014 | Volume 9 | Issue 1 | e86245
the three groups was between the AF/SR and AF/AF groups
(p,0.001), although the effect size was moderate with 17% higher
median PITX2c expression levels (antilog2 transformed) in the AF/
AF vs. AF/SR groups. After adjusting for sex and age, the
relationship between PITX2c expression and AF history/rhythm
was maintained (p,161024 overall), with 24% higher median
PITX2c expression (antilog2 transformed) in the AF/AF vs. AF/
SR groups (p,0.001, Figure 3B).
We then looked at each covariate individually for an association
with PITX2c expression. Age, history of hypertension, and history
of MVD were all significantly associated with PITX2c expression at
p,0.05; and, history of CAD had a trend with p = 0.07. The
strongest covariate associated with PITX2c expression was rhythm
status in those with a history of AF, such that PITX2c expression in
the AF/SR group was significantly different from those in the AF/
AF group (p = 9.1461024, Table 5). However in a multivariate
model adjusting for all covariates, the only covariates significantly
associated with PITX2c expression were age (p = 5.7961023,
Table 5) and rhythm status in those with a history of AF, such that
PITX2c expression in the AF/SR group was significantly different
from those in the AF/AF group (p = 4.5961023, Table 5). In the
multivariate analysis the log2 effect size and direction on PITX2c
expression for each covariate is indicated by the b coefficient.
PITX2c cis-eQTLs
We assessed the four independent AF SNPs on chromosome
4q25 for association with the expression of PITX2c, thus probing
whether these SNPs serve as cis-eQTLs for PITX2c. None of these
SNPs were associated with PITX2c levels when normalized to
ACTC1, a cardiomyocyte-specific reference gene (p$0.15,
Table 6) or when normalized to PPIA, a reference gene expressed
in all cell types (p$25, Table 7). After adjusting PITX2c expression
for sex, age, donor status, and AF history/rhythm there still was no
association of these four SNPs with expression of PITX2c (Tables 6,
7). We were well powered to detect SNPs effects on the expression
of PITX2c in the 239 human left atrial appendages, with 99%
power to observe a 15% log2 fold change in PITX2c expression
(Table 8). In order to determine if we could uncover any cryptic
associations in any rhythm subgroup, we evaluated each of the
three AF history/rhythm groups to determine if there were any
significant associations of these four SNPs with unadjusted or
adjusted PITX2c expression. No significant associations were
discovered at p,0.05 in any of the subgroups (Table 9). Among
the 40 No AF subjects, we had moderate power to detect SNP
effects on PITX2c expression, with 38% and 78%power to observe
a 15% and 35% log2 fold change in PITX2c expression,
respectively (Table 8). Upon analysis of genotyped SNPs over
the region +/2500 kb from PITX2c, there were seven SNPs
outside of the expected p-value range in QQ plots that were
associated with the adjusted PITX2c expression levels (Figure 4).
These SNPs were associated with PITX2c expression at p,0.01,
with the top SNP at p = 3.061024 (Figure 5, Table 9). These SNPs
are located within introns of the ENPEP gene, which is proximal
on chromosome 4 to the PITX2 gene; while the AF associated
SNPs are distal to PITX2. These seven SNPs are all in LD with
each other and thus represent one haplotype block (r2 from 0.292
to 1, Table 10).
PITX2c Expression is Inversely Correlated with SHOX2
Expression
SHOX2 is a transcription factor that plays a role during
embryonic development promoting the formation of the sinoatrial
node [16]. In mice, Shox2 is repressed by Pitx2, as demonstrated
by higher Shox2 mRNA levels in Pitx22/+ vs. Pitx2+/+ mouse
hearts [12]. Bioinformatic analysis identified a conserved Pitx2c
recognition element in the 2nd intron of the Shox2 gene [12].
Reporter gene transfections confirmed that Pitx2c directly
represses gene expression via this recognition element in the Shox2
gene [12]. We measured SHOX2 expression by qRT-PCR to
examine whether there was a correlation between PITX2c and
SHOX2 expression in the human left atrial appendages. We found
an inverse correlation between PITX2c and SHOX2 expression in
Table 8. Power Analysis for PITX2c expression.




*Covariates were age, sex, donor status, and SNP yielding 3 degrees of freedom.
#Covariates were age, sex, donor status, 3 AF history/rhythm at surgery groups, and SNP yielding 6 degrees of freedom.
doi:10.1371/journal.pone.0086245.t008
Table 9. P-values for AF SNPs association with PITX2c expression in individual AF history/rhythm groups.
No AF (N = 40) AF/SR (N = 78) AF/AF (N = 121)
SNP Uncorrected Corrected* Uncorrected Corrected# Uncorrected Corrected#
rs2200733 0.267 0.513 0.189 0.110 0.978 0.886
rs3853445 0.522 0.451 0.863 0.998 0.374 0.448
rs1448818 0.832 0.917 0.157 0.119 0.789 0.652
rs10033464 0.422 0.122 0.237 0.302 0.518 0.592
*corrected for age, sex, and donor status.
#corrected for age, sex, BMI, and history of hypertension, CAD, and MVD.
doi:10.1371/journal.pone.0086245.t009
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these samples (r = 20.20, p = 0.0021, Figure 6a). Additionally we
further analyzed the results based on AF history/rhythm status
and found an even stronger inverse correlation within the
subgroup with no history of AF (r = 20.47, p = 0.0023,
Figure 6b), while this correlation was not significant in the AF/
SR and AF/AF groups.
Discussion
Analysis of our Cleveland Clinic Lone AF GWAS data revealed
four independent AF associated SNPs in the chromosome 4q25
region, the strongest being the previously identified rs2200733
SNP, which had an odds ratio of 2.47 (p = 1.8610225). This odds
ratio is higher than those previously reported of 1.4 to 2 [3–5],
which we attribute to the use of a lone AF cohort. Genetic
susceptibility in the lone AF cohort may play a larger role in AF
pathogenesis than in a mixed cohort of AF subjects, in which many
of the cases may be secondary to structural heart diseases such as
CAD and MVD. We then utilized 239 human adult left atrial
appendages to determine whether these four independent AF
SNPs were associated with expression of PITX2c, the gene closest
to these SNPs, although rs2200733 is 150.6 kb distal to the PITX2
gene on chromosome 4. While these SNPs were not associated
with expression of PITX2c in adult human left atrial appendage
tissues, we did find seven SNPs in introns of ENPEP, proximal to
the PITX2 gene, that were associated with PITX2c expression.
PITX2c expression was associated with AF rhythm status, such
that there was significantly increased expression of PITX2c in the
AF/AF groups compared to the AF/SR group. This was
surprising because we predicted that PITX2c expression might
decrease with AF burden, since Pitx2c2/+ mice are susceptible to
pacing-induced atrial arrhythmia [12]; yet, the highest PITX2c
expression we observed was in the AF/AF group. A prior study
using surgically obtained atrial tissues from only 5 No AF and 5
matched AF subjects found that PITX2c expression was lower in
4/5 of the AF subjects than the No AF controls [17]; however, the
current study has a much larger sample size, allowing a
multivariate regression model to compare PITX2c expression
levels among the various rhythm groups. It is known that AF,
especially permanent AF, is associated with structural, contractile,
and electrophysiological remodeling [18,19]. It has been suggested
that AF induces a cellular adaptation through de-differentiation
into a more fetal-like cell phenotype that promotes cell survival
during stress [19–21]. Using a mouse model where lacZ was
knocked into the Pitx2 gene, Wang et al. demonstrated that Pitx2
expression is highest in the left atrium in 3-day old mice, moderate
in the left atrium of 42-day old mice, and only expressed in a few
residual cells of the left atrium in 1-year old mice [12]. Thus, we
Table 10. Linkage disequilibrium (r2) between significant PITX2c eQTL SNPs located in the ENPEP Gene.
SNP name rs11731078 rs2348427 rs2881913 rs639194 rs16997154 rs1448808 rs6533524
PITX2
p-value Chr 4 bp Intron
rs11731078 1 3.04E-04 111645790 3rd
rs2348427 0.571 1 3.07E-04 111633848 3rd
rs2881913 0.571 1 1 3.07E-04 111635731 3rd
rs639194 0.915 0.505 0.505 1 2.06E-03 111669772 10th
rs16997154 0.298 0.522 0.522 0.245 1 2.56E-03 111638646 3rd
rs1448808 0.44 0.802 0.802 0.485 0.501 1 2.67E-03 111665036 10th
rs6533524 0.341 0.68 0.68 0.292 0.55 0.519 1 4.42E-03 111626900 1st
doi:10.1371/journal.pone.0086245.t010
Figure 6. Correlation analysis of PITX2c with SHOX2 expression
in human left atrial appendages. A. SHOX2 expression was
inversely correlated with PITX2c expression in all 239 subjects
(r = 20.20 p = 0.0021) B. Among the three AF status/rhythm groups,
the inverse correlation between SHOX2 and PITX2c was only found in
the No AF subgroup (r = 20.47, p = 0.0023).
doi:10.1371/journal.pone.0086245.g006
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speculate that the fetal-like reprogramming associated with
increased AF burden might lead to the reactivation of PITX2c
expression in previously non-expressing cells and explain why we
observed the highest PITX2c levels in the AF/AF group. Overall,
we found that PITX2c expression in the subjects with no history of
AF was not statistically different than its expression in the subjects
with a history of AF; thus, PITX2c expression levels in adult left
atrial appendages cannot be used to distinguish AF cases from
controls.
We predicted that the AF-associated SNPs at chromosome 4q25
might regulate left atrial expression of PITX2c; however, our
results were not consistent with this hypothesis in the adult left
atrial appendages. This negative finding may have resulted from
examining PITX2c expression at the wrong time and/or wrong
place. For example, it might be possible to identify the effect of
these SNPs on PITX2c expression in left atrial tissue from
neonates, where PITX2c expression may be expressed highly in
all left atrial cardiomyocytes. However, we speculate that the
effects of these SNPs on expression may be lost in the residual cells
that retain PITX2c expression in adult left atria, where epigenetic
modifications may mask the SNP effects. Furthermore, Pitx2
expression in the lacZ knock-in mouse was very high in the
pulmonary vein region of 3-day old mice [12]; and the pulmonary
vein region is the target of therapeutic ablation that often
suppresses AF. Thus, it is possible that the AF-associated SNPs
regulate PITX2c expression in the pulmonary vein, but not in the
left atrial appendage. Another possibility is that the AF-associated
SNPs actually control the expression of other adjacent protein
coding or non-coding genes that are involved in AF pathogenesis,
even though PITX2 is the closest gene.
One approach that might be used to identify functional activity
of the regions containing the four AF-associated SNPs would be
the identification of enhancer/silencer activity using reporter gene
transfection studies, or using transgenic mice or zebrafish.
However, a caveat to this strategy is that heart enhancers have
been shown to be weakly conserved even between humans and
mice, thus limiting the efficacy of animal models that could be
used to investigate heart enhancer functional activity [22].
We identified several SNPs, located in introns one, three, and
ten of the ENPEP gene that were associated with expression of
PITX2c in human adult left atrial appendages. The ENPEP gene
codes for glutamyl aminopeptidase or aminopeptidase A (APA).
APA is a homodimeric type II membrane-bound protease [23]
that converts angiotensin (Ang) II to Ang III by cleaving the N-
terminal aspartic acid residue of Ang II [24]. Ang III is a potent
agonist of the angiotensin receptor type 1, and there is evidence
that it may have a more important role than Ang II in the brain in
sustaining hypertension in the spontaneous hypertensive rat
[25,26]. However, the Enpep knockout mouse displays hyperten-
sion, arguing that APA also plays a systemic role in the catabolism
of angiotensin activity [24]. A human GWAS has shown that a
common SNP in ENPEP, rs6825911, is associated with hyperten-
sion in East Asians [27]. This SNP is in weak LD with rs16997154
in Asians (r2 = 0.321 in the Asian populations, HapMap release
2.2), which we found to be an eQTL for PITX2c expression in
subjects of European ancestry. However, the SNPs in ENPEP that
we identified as PITX2c eQTLs in adult left atria were not
associated with lone AF in our GWAS (Figure 2) or for AF in prior
GWAS. Thus, we found no connection between PITX2c
expression, its association with SNPs in the ENPEP gene [3],
and susceptibility to AF.
In our cohort, we confirmed that PITX2c expression was
inversely correlated with SHOX2 expression as seen in a mouse
study [12]; however when analyzing the data based on rhythm
status, only the group with no history of AF remained significant.
We found this surprising, because we would have expected to
observe a significant inverse correlation in all subgroups. This
suggest that tissue remodeling and/or epigenetic changes in
disease conditions may override the direct effect of PITX2c on
SHOX2 expression, thus rendering the no AF history group better
for analysis of transcription factor associations with their
downstream targets.
Our study was limited by the restricted availability of atrial
appendages from subjects with no history of AF. The No AF group
consisted of 40 subjects, 24 subjects undergoing cardiac surgery for
medical reasons plus 16 donor samples that were not used for
transplantation. Within this No AF group, we still found no
association of any of the four AF associated SNPs with PITX2c
expression; however, we had only moderate power to find eQTLS
in this subgroup (Table 8). In general, fewer surgical samples are
available currently, as catheter ablation has become more
common than surgical ablation for AF treatment, and because
left atrial appendage resections have become less common with the
introduction of left atrial appendage exclusion devices. In
conclusion, we found no evidence that the AF risk SNPs at
chromosome 4q25 are associated with PITX2c expression in adult
left atrial appendages, and we suggest that these risk SNPs may be
regulating PITX2c and/or other nearby genes during development
or in the pulmonary vein region.
Author Contributions
Conceived and designed the experiments: JDS DRVW MKC JB SRGP
JH. Performed the experiments: SRGP. Analyzed the data: SRGP JH
DRVW MKC JB JDS. Contributed reagents/materials/analysis tools:
AMG GP DWN CSM PH MKC DRVW. Wrote the paper: SRGP JH
DRVW MKC JB JDS.
References
1. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, et al. (2009)
Prevention of atrial fibrillation: Report from a national heart, lung, and blood
institute workshop. Circulation 119: 606–618.
2. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, et al. (2004) Lifetime
risk for development of atrial fibrillation: The framingham heart study.
Circulation 110: 1042–1046.
3. Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, et al. (2012) Meta-
analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 44:
670–675.
4. Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, et al. (2010) Common
variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 42:
240–244.
5. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, et al.
(2007) Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature
448: 353–357.
6. Lubitz SA, Sinner MF, Lunetta KL, Makino S, Pfeufer A, et al. (2010)
Independent susceptibility markers for atrial fibrillation on chromosome 4q25.
Circulation 122: 976–984.
7. Cox CJ, Espinoza HM, McWilliams B, Chappell K, Morton L, et al. (2002)
Differential regulation of gene expression by PITX2 isoforms. J Biol Chem 277:
25001.
8. Hsu J, Hanna P, Van Wagoner DR, Barnard J, Serre D, et al. (2012) Whole
genome expression differences in human left and right atria ascertained by RNA
SequencingClinical perspective. Circulation: Cardiovascular Genetics 5: 327–
335.
9. Liu C, Liu W, Lu MF, Brown NA, Martin JF (2001) Regulation of left-right
asymmetry by thresholds of Pitx2c activity. Development 128: 2039–2048.
10. Postma AV, Christoffels VM, Bezzina CR (2011) Developmental aspects of
cardiac arrhythmogenesis. Cardiovasc Res 91: 243–251.
11. Lin CR, Kioussi C, O9Connell S, Briata P, Szeto D, et al. (1999) Pitx2 regulates
lung asymmentry, cardiac positioning and pituitary and tooth morphogenesis.
Nature 401: 279–281.
12. Wang J, Klysik E, Sood S, Johnson RL, Wehrens XHT, et al. (2010) Pitx2
prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker
specification. Proceedings of the National Academy of Sciences 107: 9753.
PITX2c Expression in Human Left Atrial Appendages
PLOS ONE | www.plosone.org 9 January 2014 | Volume 9 | Issue 1 | e86245
13. Schaub MA, Boyle AP, Kundaje A, Batzoglou S, Snyder M (2012) Linking
disease associations with regulatory information in the human genome. Genome
Res 22: 1748–1759.
14. Reich DE, Goldstein DB (2001) Detecting association in a case-control study
while correcting for population stratification. Genet Epidemiol 20: 4–16.
15. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the
comparative CT method. Nature protocols 3: 1101–1108.
16. Liu H, Espinoza-Lewis RA, Chen C, Hu X, Zhang Y, et al. (2012) The role of
Shox2 in SAN development and function. Pediatr Cardiol: 1–8.
17. Chinchilla A, Daimi H, Lozano-Velasco E, Dominguez JN, Caballero R, et al.
(2011) PITX2 insufficiency leads to atrial electrical and structural remodeling
linked to arrhythmogenesis. Circulation: Cardiovascular Genetics 4: 269–279.
18. Allessie M, Ausma J, Schotten U (2002) Electrical, contractile and structural
remodeling during atrial fibrillation. Cardiovasc Res 54: 230–246.
19. Barth AS, Merk S, Arnoldi E, Zwermann L, Kloos P, et al. (2005)
Reprogramming of the human atrial transcriptome in permanent atrial
fibrillation: Expression of a ventricular-like genomic signature. Circ Res 96:
1022–1029.
20. Ausma J, Thone F, Dispersyn G, Flameng W, Vanoverschelde J, et al. (1998)
Dedifferentiated cardiomyocytes from chronic hibernating myocardium are
ischemia-tolerant. Mol Cell Biochem 186: 159–168.
21. Thijssen VL, Ausma J, Borgers M (2001) Structural remodelling during chronic
atrial fibrillation: Act of programmed cell survival. Cardiovasc Res 52: 14–24.
22. Blow MJ, McCulley DJ, Li Z, Zhang T, Akiyama JA, et al. (2010) ChIP-seq
identification of weakly conserved heart enhancers. Nat Genet 42: 806–810.
23. Vazeux G, Wang J, Corvol P, Llorens-Cortès C (1996) Identification of
glutamate residues essential for catalytic activity and zinc coordination in
aminopeptidase A. J Biol Chem 271: 9069–9074.
24. Mitsui T, Nomura S, Okada M, Ohno Y, Kobayashi H, et al. (2003)
Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient
mice. Mol Med 9: 57–62.
25. Reaux A, Iturrioz X, Vazeux G, Fournie-Zaluski M, David C, et al. (2000)
Aminopeptidase A, which generates one of the main effector peptides of the
brain renin–angiotensin system, angiotensin III, has a key role in central control
of arterial blood pressure. Biochem Soc Trans 28: 435–440.
26. Wright JW, Mizutani S, Harding JW (2012) Focus on brain angiotensin III and
aminopeptidase A in the control of hypertension. International Journal of
Hypertension 2012.
27. Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, et al. (2011) Meta-analysis of
genome-wide association studies identifies common variants associated with
blood pressure variation in East Asians. Nat Genet 43: 531–538.
PITX2c Expression in Human Left Atrial Appendages
PLOS ONE | www.plosone.org 10 January 2014 | Volume 9 | Issue 1 | e86245
